Company Overview of Algipharma AS
Algipharma AS operates as a biopharmaceutical company that develops and markets medical therapies for the treatment of respiratory diseases and wound healing. The company offers OligoG, a device that focuses on the treatment of cystic fibrosis, chronic obstructive pulmonary diseases, infectious diseases, and wounds and burns. Algipharma AS was founded in 2006 and is based in Sandvika, Norway.
Founded in 2006
47 67 54 57 70
Key Executives for Algipharma AS
Similar Private Companies By Industry
|Ayanda Group AS||Europe|
|Biolink Group AS||Europe|
|C10 Pharma A/S||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Algipharma AS, please visit www.algipharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.